Cargando…
MSCV-based retroviral plasmids expressing 3xFLAG-Sp-dCas9 for enChIP analysis
Engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) is a technology for purifying specific genomic regions to facilitate identification of their associated molecules, including proteins, RNAs, and other genomic regions. In enChIP, the target genomic region is tagged with...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365529/ https://www.ncbi.nlm.nih.gov/pubmed/34409168 http://dx.doi.org/10.1093/biomethods/bpab013 |
_version_ | 1783738726178881536 |
---|---|
author | Yuno, Miyuki Nagata, Shoko Fujita, Toshitsugu Fujii, Hodaka |
author_facet | Yuno, Miyuki Nagata, Shoko Fujita, Toshitsugu Fujii, Hodaka |
author_sort | Yuno, Miyuki |
collection | PubMed |
description | Engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) is a technology for purifying specific genomic regions to facilitate identification of their associated molecules, including proteins, RNAs, and other genomic regions. In enChIP, the target genomic region is tagged with engineered DNA-binding molecules, for example, a variant of the clustered regularly interspaced short palindromic repeats (CRISPR) system consisting of a guide RNA (gRNA) and a catalytically inactive form of Cas9 (dCas9). In this study, to increase the flexibility of enChIP and expand the range of target cells, we generated murine stem cell virus (MSCV)-based retroviral plasmids for expressing dCas9. We constructed MSCV-based retroviral plasmids expressing Streptococcus pyogenes dCas9 fused to a 3xFLAG-tag (3xFLAG-Sp-dCas9) and various drug resistance genes. We showed that by using these plasmids, it is feasible to purify target genomic regions with yields comparable to those reported using other systems. These systems might give enChIP users greater flexibility in choosing optimal systems for drug selection of transduced cells. |
format | Online Article Text |
id | pubmed-8365529 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-83655292021-08-17 MSCV-based retroviral plasmids expressing 3xFLAG-Sp-dCas9 for enChIP analysis Yuno, Miyuki Nagata, Shoko Fujita, Toshitsugu Fujii, Hodaka Biol Methods Protoc New Materials Engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) is a technology for purifying specific genomic regions to facilitate identification of their associated molecules, including proteins, RNAs, and other genomic regions. In enChIP, the target genomic region is tagged with engineered DNA-binding molecules, for example, a variant of the clustered regularly interspaced short palindromic repeats (CRISPR) system consisting of a guide RNA (gRNA) and a catalytically inactive form of Cas9 (dCas9). In this study, to increase the flexibility of enChIP and expand the range of target cells, we generated murine stem cell virus (MSCV)-based retroviral plasmids for expressing dCas9. We constructed MSCV-based retroviral plasmids expressing Streptococcus pyogenes dCas9 fused to a 3xFLAG-tag (3xFLAG-Sp-dCas9) and various drug resistance genes. We showed that by using these plasmids, it is feasible to purify target genomic regions with yields comparable to those reported using other systems. These systems might give enChIP users greater flexibility in choosing optimal systems for drug selection of transduced cells. Oxford University Press 2021-07-09 /pmc/articles/PMC8365529/ /pubmed/34409168 http://dx.doi.org/10.1093/biomethods/bpab013 Text en © The Author(s) 2021. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | New Materials Yuno, Miyuki Nagata, Shoko Fujita, Toshitsugu Fujii, Hodaka MSCV-based retroviral plasmids expressing 3xFLAG-Sp-dCas9 for enChIP analysis |
title | MSCV-based retroviral plasmids expressing 3xFLAG-Sp-dCas9 for enChIP analysis |
title_full | MSCV-based retroviral plasmids expressing 3xFLAG-Sp-dCas9 for enChIP analysis |
title_fullStr | MSCV-based retroviral plasmids expressing 3xFLAG-Sp-dCas9 for enChIP analysis |
title_full_unstemmed | MSCV-based retroviral plasmids expressing 3xFLAG-Sp-dCas9 for enChIP analysis |
title_short | MSCV-based retroviral plasmids expressing 3xFLAG-Sp-dCas9 for enChIP analysis |
title_sort | mscv-based retroviral plasmids expressing 3xflag-sp-dcas9 for enchip analysis |
topic | New Materials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365529/ https://www.ncbi.nlm.nih.gov/pubmed/34409168 http://dx.doi.org/10.1093/biomethods/bpab013 |
work_keys_str_mv | AT yunomiyuki mscvbasedretroviralplasmidsexpressing3xflagspdcas9forenchipanalysis AT nagatashoko mscvbasedretroviralplasmidsexpressing3xflagspdcas9forenchipanalysis AT fujitatoshitsugu mscvbasedretroviralplasmidsexpressing3xflagspdcas9forenchipanalysis AT fujiihodaka mscvbasedretroviralplasmidsexpressing3xflagspdcas9forenchipanalysis |